PG
IRWD icon

PEAK6 Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

PEAK6 Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-21,014
Closed -$270K – 4894
2014
Q2 		$270K Buy
21,014
+12,059
+135% +$131K ﹤0.01% 2914
2014
Q1 		$92K Buy
+8,955
New +$101K ﹤0.01% 3997
2013
Q4 		– Sell
-76,177
Closed -$378K – 5137
2013
Q3 		$378K Buy
+76,177
New +$747K ﹤0.01% 3063

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PEAK6 Group's IRWD Position: Q2 2014 in Review

PEAK6 Group sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2014, closing a stake of 21,672 shares — an estimated $236K sold.

PEAK6 Group first reported a position in IRWD in Q3 2013 and held it in 3 quarters. The position peaked at $603K in Q3 2013. 138 funds tracked by Wall St. Rank hold IRWD as of Q2 2014.

  • PEAK6 Group reported no remaining Ironwood Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • PEAK6 Group sold 21,672 Ironwood Pharmaceuticals shares in Q2 2014, an estimated $236K.
  • PEAK6 Group first reported a position in Ironwood Pharmaceuticals in Q3 2013 and held it in 3 quarters.
  • PEAK6 Group's Ironwood Pharmaceuticals position peaked at $603K in Q3 2013.
  • 138 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2014.

Based on PEAK6 Group's 13F filing for Q2 2014, filed 14 Aug 2014.